Congratulations to the @bonellilab.bsky.social on this work on understanding how patients respond to MTX in the first weeks. Proud that members of SQUEEZE contributed to this work, which aligns closely with our mission of optimising treatment selection in #RA. linkinghub.elsevier.com/retrieve/pii...

New in "Rheumatology": analysis of 64 clinical trials creates a standardised "safety gestalt" for #RA treatments. Same serious side effect rates across drugs, but each has its own safety pattern - helping doctors choose the best fit for each patient. #RheumatoidArthritis doi.org/10.1093/rheu...

Learn more about the SQUEEZE project in our most recent newsletter edition, accessible via LinkedIn: www.linkedin.com/pulse/squeez... #RheumatoidArthritis #RA #EUprojects #HorizonEurope

SQUEEZE newsletter - issue no6

Let's squeeze the best out of existing treatments in rheumatoid arthritis (RA). Welcome to the sixth issue of our bi-annual SQUEEZE newsletter - and what a busy half-year this has been! From a major r...

linkedin.com

The #stakeholder engagement strategy of the #SQUEEZE project was showcased at the Spanish and Portuguese Epidemiology Congress #SEE2026 #APE2026 in Pamplona. See below a summary in Spanish! @squeezeproject.bsky.social

What a fantastic #EULAR2026 in London! Proud of the outstanding scientific contributions from our Division of Rheumatology @meduniwien.ac.at, from talks, posters and chairing to leadership in key sessions. Great visibility also for @squeezeproject.bsky.social and @autopix.bsky.social!

While in SQUEEZE we are researching Torque Teno Virus in #RA, a European team of nephrologists also led by @meduniwien.ac.at has recently shared first results on their investigator-intiated, multicentre, patient+central assessor-blinded, non-inferiority, randomized controlled phase II trial on #TTV.

MedUni Wien@meduniwien.ac.at · 2mo ago

Successful trial ✅️ An international team coordinated by #MedUniVienna demonstrated in a #clinicaltrial that #TorqueTenovirus-guided dosing of #immunosuppressants in #kidneytransplant recipients is safe. More about the @ttvguidetx.bsky.social​ study coordinated by @gregorbond.bsky.social​! ⬇️

While #EULAR2026 is slowly coming to an end, there's still more interesting contributions happening today. Join @simonsteiger.bsky.social and @nilssteinz.bsky.social at the poster view session starting at 10:15 am BST. 👇👇👇

Katy Antonopoulou shows a clear care gap: The rheumatologist may focus on RMD medication and disease activity. The gynaecologist/menopause specialist may focus on menopause symptoms. But the patient falls in the middle. That gap needs to close. #EULAR2026

Katy Antonopoulou’s recommendations to the clinical community are clear: Ask about menopause. Refer proactively. Reassure and inform patients. Work with patient associations. Advocate for multidisciplinary menopause-RMD clinics. #EULAR2026

Definitely one of our #EULAR2026 highlights: a very SQUEEZE-heavy line-up at the session "Please mind the gap: Approaches to implementing research into rheumatology practice" with @agneskocher2.bsky.social, @sabinadegeest.bsky.social, @estitxuloza.bsky.social & our patient research partner Ria. 💙👩👩‍🦱👩‍🦰

Full house at the poster tour of SQUEEZE expert Karolina Anderle from @meduniwien.ac.at on Day 3 of #EULAR2026! Karolina presented the determinants of methotrexate polyglutamate levels, the monitoring of which pose a great potential for personalised optimisation in MTX therapy.

Please help us by completing this survey on the availability, accessibility & affordability of #RA treatments across Europe. The results will help identify disparities in the treatment access across Europe & support future evidence-based recommendations for more equitable care. #EULAR2026

Time flies and it's already Day3 at #EULAR2026 where today at 9 am BST we will join a workshop led by @autopix.bsky.social on Stakeholder Involvement in EU-funded research. The workshop will be focusing on interactions with policymakers, regulators, and authorities. Very excited to meet everyone!

Therapy (DMARD) adherence is often poorly measured, that's why SQUEEZE developed a Care Model to improve adherence. This ehealth facilitated Model is being piloted in Switzerland with the goal to enhance routine rheumatological care. #EULAR2026 @agneskocher2.bsky.social @sabinadegeest.bsky.social

Our patient research partner Ria Brokken shares learnings of her work as a patient partner in the implementation of research into Rheumatology practice at #EULAR2026. We are lucky to have a full patient research panel supporting us in our clinical trials & the development of the SQUEEZE Care Model 💙

Why do promising healthcare innovations often fail to reach patients? 🤔 Today, SQUEEZE contributes to "Please mind the gap: Approaches to implementing research into Rheumatology Practice" starting 2:45 pm with talks on patient engagement & implementation science #EULAR2026 @agneskocher2.bsky.social

Did you notice the large crowd of people in the NPO area last night just before the networking dinner at #EULAR2026? There's heaps of passionate clinicians, scientists, HCP, & patients involved in a large number of EU consortia like SQUEEZE - come by at booth **O17** and learn more about our work!

Still wondering what SQUEEZE does? Learn more about our work in this @ec.europa.eu Horizon Magazine article: projects.research-and-innovation.ec.europa.eu/en/horizon-m... Intrigued? Come visit us at booth 📍O17 in the NPO section of #EULAR2026.

Squeezing more from arthritis drugs to help patients live better

Over the past two decades, a wave of new drug treatments for rheumatoid arthritis (RA) has allowed many people to live free from pain, joint swelling and long-term disability. But for many patients in...

projects.research-and-innovation.ec.europa.eu

Harriet Morf, from the #SPIDeRR project had an spontaneous fast presentation during the HPR #EULAR26 fishbowl on digital health. DYK that 🇩🇪 already has an app in #axSpA? #Axia

At #EULAR2026, we recently presented the SQUEEZE experience at the PARE poster tour: a 3-year study developing, implementing and evaluating a stakeholder involvement strategy for a complex multinational RA research project, including patients, clinicians, researchers and other end users.

Shout out to our neighbours over at @mdr-ra-project.bsky.social - some of us might get confused these days at #EULAR2026 with all the EU consortia we are involved in. 🤪 We trust though that more collaboration will only lead to more learnings, better understanding & better lives for patients with #RA

🔔 Don't miss our first contribution at #EULAR2026! Estibaliz Loza Santamaria, @inmusc.bsky.social presents the SQUEEZE experience on stakeholder involvement in a multinational research project: 📍PARE Poster Tour 🕓 16:18 BST Because meaningful research is stronger when stakeholders help shape it.💙

💂‍♂️ London, we're ready! The SQUEEZE booth is set up and we're ready for #EULAR2026. Over the next few days we'll be sharing insights from our contributions and discussing how to maximise the impact of treatments for people living with #RheumatoidArthritis. 💙 Come say hello! 👋📍 O17 in the NPO area.

🌍 Few events bring together patients, researchers, clinicians, health professionals, & industry quite like #EULAR2026. We're now headed to the opening plenary to support the @eular.org president's Xenofon Baraliakos' inaugural speech. What's it gonna be this year? Bring popcorn & join us there! 😎🛴🎬🍿

SQUEEZE is coming to #EULAR2026! Getting ready to set up camp at Excel London for the next 4 days. 📍Come join us at booth **O17** & chat with our SQUEEZE ambassadors @caro-neum.bsky.social and Marta Sobrado from @meduniwien.ac.at and @qmul.bsky.social about our work on precision medicine in #RA.

🧳 It's #EULAR2026 week! Over the coming days, our team will share insights from SQUEEZE contributions, posters, workshops, and discussions in London - from patient involvement & implementation science to precision medicine & treatment optimisation in #RheumatoidArthritis. Join us for the ride! 👇

4th virtual @squeezeproject.bsky.social consortium meeting done. A moment to reflect on 3.5 years of work improving RA care and align on the road to Nov next year. Thanks to all of our partners!

💡 We don’t necessarily need more drugs for #RA - we need to use existing ones more effectively. Here's a recent article of the @ec.europa.eu's HORIZON magazine on SQUEEZE, feat. @danielaletaha.bsky.social & @agneskocher2.bsky.social projects.research-and-innovation.ec.europa.eu/en/horizon-m...

High disease activity is high disease activity is high disease activity? - Nope! Not all patients with rheumatoid arthritis are the same – even when they have exactly the same disease activity score! Full article: pubmed.ncbi.nlm.nih.gov/41839530/ Part of #SPIDERR and @squeezeproject.bsky.social

Can alternative means of phenotyping rheumatoid arthritis reduce its apparent heterogeneity? A comparison of three disease activity classifications with DAS28 - PubMed

Separating subjective and objective dimensions reveals different RA patient profiles that are grouped together by DAS28, demonstrating the extent to which DAS28 is confounded by factors beyond RA disease activity. Disentangling and treating heterogeneous RA patient profiles may therefore require mor …

pubmed.ncbi.nlm.nih.gov